BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32194797)

  • 1. Activated STAT3 Could Reduce Survival in Patients with Esophageal Squamous Cell Carcinoma by Up-regulating VEGF and Cyclin D1 Expression.
    Zhang N; Zhang M; Wang Z; Gao W; Sun ZG
    J Cancer; 2020; 11(7):1859-1868. PubMed ID: 32194797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
    Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
    [No Abstract]   [Full Text] [Related]  

  • 3. STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma.
    Zhang Q; Zhang C; He J; Guo Q; Hu D; Yang X; Wang J; Kang Y; She R; Wang Z; Li D; Huang G; Ma Z; Mao W; Zhou X; Xiao C; Sun X; Ma J
    Tumour Biol; 2015 Mar; 36(3):2135-42. PubMed ID: 25492480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Constitutive activation of signal transducers and activators of transcription 3 and expression of its target gene products in human ESCC cell line].
    Wang XH; Li SS; Yan AH; Lu CX; Guo YP
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):441-4. PubMed ID: 16624747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual high expression of STAT3 and cyclinD1 is associated with poor prognosis after curative resection of esophageal squamous cell carcinoma.
    Li H; Xiao W; Ma J; Zhang Y; Li R; Ye J; Wang X; Zhong X; Wang S
    Int J Clin Exp Pathol; 2014; 7(11):7989-98. PubMed ID: 25550842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
    Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
    Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tumor metastasis-associated markers for molecular classification in patients with esophageal squamous cell carcinoma.
    Huang JX; Yao J; Lin MS; Lin M; Xiao W; Yu H; Chen P; Qian RY
    Int J Clin Exp Med; 2015; 8(9):15920-9. PubMed ID: 26629095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
    Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
    Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting MYO1B impairs tumorigenesis via inhibiting the SNAI2/cyclin D1 signaling in esophageal squamous cell carcinoma.
    Li SH; Qian L; Chen YH; Lu HI; Tsai HT; Lyu H; Yang R; Chen CH
    J Cell Physiol; 2022 Sep; 237(9):3671-3686. PubMed ID: 35861939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
    Yang Z; Cui Y; Ni W; Kim S; Xuan Y
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation.
    Lassmann S; Schuster I; Walch A; Göbel H; Jütting U; Makowiec F; Hopt U; Werner M
    J Clin Pathol; 2007 Feb; 60(2):173-9. PubMed ID: 17264243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
    Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
    Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
    J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway.
    Jian J; Li S; Liu LZ; Zhen L; Yao L; Gan LH; Huang YQ; Fang N
    Int J Mol Med; 2020 Jul; 46(1):201-210. PubMed ID: 32377720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma.
    Zhao X; Tang YP; Wang CY; Wu JX; Ye F
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic significance of MUC1 expression in patients with esophageal squamous cell carcinoma after radical resection.
    Sun ZG; Yu L; Gao W; Wang Z; Zhu LM
    Saudi J Gastroenterol; 2018; 24(3):165-170. PubMed ID: 29798942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of
    Wang H; Zhou Y; Liu Q; Xu J; Ma Y
    Onco Targets Ther; 2018; 11():5171-5181. PubMed ID: 30210237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.